PRELUDE CAPITAL MANAGEMENT, LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 118 filers reported holding TG THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$491,167
+112.1%
58,752
+530.3%
0.03%
+113.3%
Q2 2023$231,558
-80.6%
9,322
-90.8%
0.02%
-76.2%
Q4 2022$1,196,332
+409.1%
101,127
+71.6%
0.06%
+687.5%
Q3 2022$235,000
-47.0%
58,927
-43.4%
0.01%
-38.5%
Q2 2022$443,000
-56.1%
104,074
-1.8%
0.01%
-55.2%
Q1 2022$1,008,000
-49.7%
105,951
+0.4%
0.03%
-43.1%
Q4 2021$2,005,000
-37.7%
105,528
+9.0%
0.05%
-37.8%
Q3 2021$3,220,000
+5451.7%
96,782
+3126.1%
0.08%
+2633.3%
Q2 2020$58,000
-74.6%
3,000
-85.4%
0.00%
-66.7%
Q4 2019$228,000
+5600.0%
20,500
+3316.7%
0.01%
Q3 2019$4,000
-50.0%
600
-33.3%
0.00%
Q2 2019$8,0000.0%900
-10.0%
0.00%
Q1 2019$8,0001,000
+1269.9%
0.00%
Q4 2018$0
-100.0%
73
-6.4%
0.00%
Q2 2018$1,000
-99.2%
78
-99.3%
0.00%
-100.0%
Q3 2014$126,000
-20.8%
11,807
-30.2%
0.02%
-18.2%
Q2 2014$159,000
+8.9%
16,925
-20.2%
0.02%
+15.8%
Q1 2014$146,00021,2050.02%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Lion Point Capital, LP 839,128$27,926,0005.24%
RA Capital Management 4,098,332$136,392,0001.89%
KLK CAPITAL MANAGEMENT LLC 45,762$1,523,0001.40%
Antara Capital LP 520,800$17,332,0001.33%
Spotlight Asset Group, Inc. 75,000$2,496,0001.24%
Nicholas Investment Partners, LP 485,838$16,169,0001.18%
MAVERICK CAPITAL LTD 3,296,451$109,706,0001.11%
SECTORAL ASSET MANAGEMENT INC 394,949$13,144,0001.09%
683 Capital Management, LLC 828,271$27,565,0001.08%
ACT CAPITAL MANAGEMENT, LLC 60,000$1,997,0001.04%
View complete list of TG THERAPEUTICS INC shareholders